Meda AB
Pharmaceuticals0-1 Employees
Meda AB is a pharmaceutical manufacturing company with a global footprint, selling its products in more than 150 countries and operating its own structures in over 60 countries. Based in Sweden, the firm is publicly listed on Nasdaq Stockholm as a Large Cap entity, and is described as a leading international specialty pharma company in its sector. The organization positions itself in the specialty pharma space, providing products that reach a broad, international customer base across multiple markets. A notable development in its history is the acquisition by Mylan in August 2016, with subsequent reporting in early 2017 confirming the completed deal.
1-888-653-2347 
support@leadiq.com 
